Rivaroxaban is an anticoagulant active pharmaceutical ingredient used in the manufacturing of medications to prevent and treat blood clots. It is an orally administered compound that acts as a direct factor Xa inhibitor.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 366789-02-8
Apixaban
pharmaceutical raw material
(RS)-warfarin
pharmaceutical raw material
Acenocoumarol
pharmaceutical raw material
Phenindione
pharmaceutical raw material
L-carnitine L-tartrate
pharmaceutical raw material
Inosine pranobex
pharmaceutical raw material
Lurasidone
pharmaceutical raw material
Lurasidone hydrochloride
pharmaceutical raw material
5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide
KGFYHTZWPPHNLQ-AWEZNQCLSA-N
C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl